New cancer drug FL115 tested in humans for first time
Disease control
Completed
This early-phase study tested a new drug, FL115, in 18 adults with advanced solid tumors that no longer responded to standard treatments. The main goal was to check safety and find the right dose. Participants received the drug weekly, and doctors watched for side effects, especi…
Phase: PHASE1 • Sponsor: Suzhou Forlong Biotechnology Co., Ltd • Aim: Disease control
Last updated May 11, 2026 20:39 UTC